With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly. Despite this growth over the last 12 months, the IO community still faces critical challenges in translating drugs to the clinic. The IO community must continue to work together to overcome critical bottlenecks around immunomodulating agent utilization, dosing and efficacy as well as looking for predictive biomarkers to boost our clinical and therapeutic index confidence. 

Read on tumor-models-sf.com

DNA damage response inhibition has amassed a lot of interest over the last decade as it exposes a massive vulnerability in cancer cells. This has a huge potential to treat many types of tumors such as breast and colorectal cancers, and even notoriously difficult-to-treat CNS tumors.

The 6th Annual DDR Inhibitors Summit will cover both the preclinical and clinical DDR inhibitor landscape and establish how the field is addressing the biggest hurdle to drug development – toxicity. From reviewing progress with both novel and established targets to utilizing inhibitors in combination studies and improving patient selection with improved biomarkers; this meeting will give a comprehensive and up-to-date overview of the field.

As we look to 2023 and what it has in store, this highly anticipated summit is back in person, bigger and better than ever before. As the industry-leading conference, join forward-thinking researchers from the pharmaceutical, biotech and academic community as they unite to share ideas on progress, challenges and novel solutions in the current DDRi climate.

Prices:

FULL PACKAGE: Conference + Pre-Conference Day - Drug Developer USD 4946.00

Conference Only - Drug Developer USD 2999.00

FULL PACKAGE: Conference + Pre-Conference Day - Academic USD 4246.00

Conference Only - Academic USD 2599.00

FULL PACKAGE: Conference + Pre-Conference Day - Solution Provider USD 5846.00

Conference Only - Solution Provider USD 3599.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals | Drug Development

Dates and Time: Starts: Tue, Jan 24, 2023 ( 9:00 AM) and Ends: Thu, Jan 26, 2023 ( 6:00 PM)

Venue details: Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Drive, Woburn, Massachusetts, 01801, United States

With an improved understanding of biology and mechanisms of action, the Wnt/B-Catenin community is surging through clinic in 2022 with positive clinical updates. The excitement of a potential first-in-class candidate to advent combination, immuno-oncology therapies in colorectal, head and neck and non-small cell lung cancer is offering hope for patients with high unmet medical needs.

After 2 decades of research, it is now the time for drug developers to act and get together at the 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit. As the one and only industry-led meeting, you will be equipped with unparalleled insights in:

- Wnt/B-Catenin's structural biology and medicinal chemistry - turning the undruggable druggable

- Comparison of different Wnt/B-Catenin modulation approaches, its interaction with TIL and tumor microenvironment for targeted, combination therapies

- Translating basic science into clinical design - from scheduling to dosing, overcoming toxicity to widen the therapeutic window with safety in mind

- Validating a clinical biomarker for patient selection

In collaboration with Wnt/B-Catenin pioneers such as Iterion Therapeutics, Leap Therapeutics, FogPharma, this is your unique opportunity to join and meet 60+ drug developers to forge long-term collaboration and advance Wnt/B-Catenin as a valuable target and clinical asset, propelling to provide first-in-class treatments for patients!

SAE Media Group is proud to present the 2nd annual Transdermal and Microneedle Drug Delivery Conference, taking place on the 23rd to 24th January 2023.

The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization. Engage in the latest innovations in device design, development and formulation, with case studies from expert key opinion leaders of this rapidly accelerating space. Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease.

The two-day agenda offers you peer-to-peer networking with CEO's, Senior Vice presidents, Directors, Heads of Product Development and many more.

BENEFITS OF ATTENDING:

- Engage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation

- Gain insights from notified body and competent authority representatives addressing key regulatory requirements

- Understand how to optimize your lifecycle management strategy for a commercially successful device

- Explore and benchmark against industry advances in device design through case studies and real-world examples

WHO SHOULD ATTEND:

- Drug-Delivery Device Developers

- Microneedle Device Developers

- Transdermal Delivery Developers

- Microarray Patch Developers

- Medical Device Engineers

- Primary Packaging Material Designers

- Secondary Packagers

- Smart Device Developers

- Training Device Developers

- Device-Safety Solution Providers

- Drug Developers

- Transdermal Drug Product Developers

EARLY-BIRD RATES:

BOOK BY 30TH SEPTEMBER AND SAVE £400 

Registrations can be made on the event website at: www.transdermal-microneedle-delivery.co.uk/EVVNT 

Time: 09:00 to 17:00

As our population becomes more diverse and at greater risk for poor health outcomes due to the impact of negative social determinants of health, there is a growing need to coordinate services across the care continuum. 

This conference will enable healthcare professionals can create a more holistic awareness of the biological, behavioral and social factors that impact health—working together to build a more equitable healthcare system that enables better health outcomes for all.

Read on brinetwork.com

As our population becomes more diverse and at greater risk for poor health outcomes due to the impact of negative social determinants of health, there is a growing need to coordinate services across the care continuum. Connecting and integrating social supports and services into healthcare provision is essential in order to address the broad range of social determinants that play such an important role in health and well-being. This conference will address how much of this can be achieved through various methods of increased collaboration among healthcare professionals, including:

• How to recognize and integrate social factors that influence health-related behaviors and health status to develop more effective treatment plans.
• Assessing and addressing social needs through appropriate referrals to ensure adequate support.
• Developing health-promotion strategies that reach into communities to improve living and working conditions.
• Conducting or supporting ongoing research regarding social determinants of health and determine which strategies may be most effective in improving health outcomes.
• Acting as a resource for local, state, and national policy makers to enable improved health equity for all Americans.

Read on brinetwork.com

The nation’s healthcare ecosystem is continuing its value-based care approach to improve the population’s health and outcomes while reducing costs. Population health management strategies and implementations are driving these efforts to achieve the Triple Aim. Both providers and payors are deeply involved in developing and deploying effective programs and processes targeted to deliver high quality, patient centric healthcare to significantly improve patient outcomes, while dramatically reducing healthcare spending. These innovative methods encompass enhanced care coordination, utilization of technology and data, preventative measures and patient engagement to manage high risk patient populations. Collaborative efforts between payors and providers, as well as partnerships are improving the patient experience while reducing spending. In addition, the COVID-19 pandemic has fundamentally changed how healthcare systems deliver services. Population health can lead as a cornerstone of a resilient health system, better prepared to improve public health and mitigate risk in a value-based paradigm.

This high-level forum features knowledgeable leaders from the nation’s leading hospitals, health systems and health plans who will share their valuable insights and expertise on how to achieve success in the rapidly evolving landscape of population health management. Attendees will benefit from learning about best practices and strategies that have been implemented to address the challenges in transforming the nation’s healthcare to improve and maintain a healthy population while reducing healthcare spending.

Read on brinetwork.com

We are currently at a crucial point in time for corporate healthcare – employers are operating in a political and economic situation that has considerably evolved. Building and expanding onsite employee health clinics has become an imperative in enabling employers to offer competitive benefits, control costs, and provide quality healthcare to employees. Moreover, employers must redefine their corporate healthcare strategy, and innovation will be key to success!

The opportunities and challenges facing onsite health clinics have drastically changed over the past year. Healthcare reform has made its way to center stage on all matters related to healthcare, and onsite employee health clinics are no exception. Employers are aggressively seeking innovative means to cut back on corporate healthcare costs, and onsite employee health clinics have proven to be an effective way to significantly reduce those healthcare costs, and ultimately, have a positive impact on the company’s bottom line. By attending the 2023 Onsite Employee Health Clinics Summit, you will learn what it takes to build and streamline facilities that meet innovative visions for healthcare and wellness. You will also learn the benefits associated with expanding current onsite health facilities. Furthermore, you will walk away with practical solutions to operate a cost-effective healthcare program while providing quality healthcare.

Read on wcforum.com

For decades, disparities in healthcare have been well documented in the U.S. and regrettably, remain prevalent despite evidence and appeals for their elimination. Compared to the majority, racial and ethnic minorities continue to have poorer health status and health outcomes for most chronic conditions. Many factors, such as affordability, accessibility and diversity in the healthcare system influence care and outcomes, creating challenges that make the task of eliminating health disparities and achieving health equity daunting and elusive. Novel strategies are needed to bring about much needed change to the complex and evolving healthcare system.

Over the past several decades, diversity in the U.S. population has increased significantly and is expected to increase exponentially in the near future. As the population becomes more diverse, it is important to recognize the possibilities of new and emerging disparities. It is imperative that steps are taken to eliminate the current gap in care and prevent new disparities from developing. This conference will present challenges and offer recommendations for facilitating the process of eliminating health disparities and achieving health equity across diverse populations. Topics to be discussed will include launching a health equity strategy, social determinants of health, digital health equity, community partnerships, population health management strategies, the healthcare supply chain, policy and more.

Read on brinetwork.com

Our mission is to help healthcare providers become exceptional in leadership, strategy and innovation, and help the entire system move towards greater value.

Consumer preference, acuity, technology, workforce, wages, workplace, government policy, risk, partnerships, etc. – all have been changed by the meteoric strike of Covid. Our 2022 program aimed to help you see the forest for the trees as we determine how our organizations will - and should - change post-pandemic. 

Read on homecare100.com